Last updated 2026-06-18
- Acquired by Lyell Immunopharma, Oct 2024
- Raised $111M funding round led by venBio, Jan 2022
- Raised $8M grant led by California Institute for Regenerative Medicine (CIRM), Feb 2024
Total raised
$137.0M
Last: Grant 2024-02
Stage
Acquired
Founded
2016
Headcount
49
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
ImmPACT Bio is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients who have exhausted their treatment options. The company's logic-gate-based CAR T platforms address key biological challenges in treating cancer. ImmPACT Bio's technologies are specifically designed to prevent antigen escape, prevent "on-target off-tumor" toxicities, and overcome the immunosuppressive tumor microenvironment.
The company's technology is based on the work of Yvonne Chen, PhD, and Antoni Ribas, MD, PhD, both from University of California, Los Angeles, and Gideon Gross, PhD, from the MIGAL-Galilee Research Institute.
Funding history · 4 rounds · $137.0M total
2024-02
2022-01
2019-06
Q&A
- What is ImmPACT Bio's primary focus?
- ImmPACT Bio is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
- When was ImmPACT Bio acquired and by whom?
- ImmPACT Bio was acquired by Lyell Immunopharma in October 2024.
- How much funding has ImmPACT Bio raised in total?
- ImmPACT Bio has raised a total of $137,000,000.
- When was ImmPACT Bio founded?
- ImmPACT Bio was founded in November 2016.
- What was ImmPACT Bio's most recent funding round?
- In February 2024, ImmPACT Bio received an $8,000,000 grant from the California Institute for Regenerative Medicine (CIRM).
- Which investors participated in ImmPACT Bio's $111,000,000 funding round in January 2022?
- The January 2022 funding round was led by venBio, with participation from OrbiMed.
- How many employees does ImmPACT Bio have?
- ImmPACT Bio has 11-50 employees.
- Where is ImmPACT Bio's headquarters located?
- ImmPACT Bio's headquarters is located in Rehovot, Israel, with an additional office in Los Angeles, USA.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
biotechnologybiopharmaceuticallife-sciencesgenetic-engineeringmedical-technologiescancer-therapyhospitalshealthcare-providersoncologycell-therapycancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | immpact-bio.com/ |
|---|---|
| linkedin.com/company/37527946 |
Identifiers & details
| Founded | 2016-11 |
|---|---|
| Employees (exact) | 49 |
| Offices | Los Angeles |
| Status reason | Acquired by Lyell Immunopharma on Oct 2024 |
Acquisitions & public offerings
Acquired by Lyell Immunopharma 2024-10
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | immpact-bio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|